Davidson Investment Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-359
Closed -$13K 197
2017
Q1
$13K Hold
359
﹤0.01% 173
2016
Q4
$13K Hold
359
﹤0.01% 187
2016
Q3
$12K Hold
359
﹤0.01% 183
2016
Q2
$11K Sell
359
-41
-10% -$1.26K ﹤0.01% 177
2016
Q1
$11K Hold
400
﹤0.01% 202
2015
Q4
$13K Buy
400
+359
+876% +$11.2K ﹤0.01% 195
2015
Q3
$1K Sell
41
-374
-90% -$13K ﹤0.01% 198
2015
Q2
$16K Buy
415
+46
+12% +$2.06K ﹤0.01% 185
2015
Q1
$18K Hold
369
﹤0.01% 170
2014
Q4
$16K Buy
+369
New +$14.5K ﹤0.01% 166

Other funds holding AVNS

Davidson Investment Advisors's AVNS Position: Q2 2017 in Review

Davidson Investment Advisors sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 359 shares — an estimated $13K sold.

Davidson Investment Advisors first reported a position in AVNS in Q4 2014 and held it in 10 quarters. The position peaked at $18K in Q1 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Davidson Investment Advisors reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Davidson Investment Advisors sold 359 Avanos Medical shares in Q2 2017, an estimated $13K.
  • Davidson Investment Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 10 quarters.
  • Davidson Investment Advisors's Avanos Medical position peaked at $18K in Q1 2015.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Davidson Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.